M. Haim, M. Hoshen, O. Reges, Y. Rabi, R. Balicer et al., Prospective National Study of the Prevalence, Incidence, Management and Outcome of a Large Contemporary Cohort of Patients With Incident Non-Valvular Atrial Fibrillation, J Am Heart Assoc 21 janv, vol.4, issue.1, 2015.

M. Zoni-berisso, F. Lercari, T. Carazza, and S. Domenicucci, Epidemiology of atrial fibrillation: European perspective, Clin Epidemiol. 16 juin, vol.6, pp.213-233, 2014.

B. P. Krijthe, A. Kunst, E. J. Benjamin, G. Lip, O. H. Franco et al., Projections on the number of individuals with atrial fibrillation in the European Union, Eur Heart J. 14 sept, vol.34, issue.35, pp.2746-51, 2000.

S. Stewart, N. Murphy, A. Walker, A. Mcguire, and J. Mcmurray, Cost of an emerging epidemic: an economic analysis of atrial fibrillation in the UK, Heart. mars, vol.90, issue.3, pp.286-92, 2004.

K. Michael, H. , J. Stephen, S. , and C. Bong-chul, Schulman Kathy L. Estimation of Total Incremental Health Care Costs in Patients With Atrial Fibrillation in the United States, Circulation: Cardiovascular Quality and Outcomes. 1 mai, vol.4, issue.3, pp.313-333, 2011.

A. Charlemagne, J. Blacher, A. Cohen, J. Collet, F. Diévart et al., Epidemiology of atrial fibrillation in France: Extrapolation of international epidemiological data to France and analysis of French hospitalization data, Archives of Cardiovascular Diseases. 1 févr, vol.104, issue.2, pp.115-139, 2011.

L. Heuzey, J. Paziaud, O. Piot, O. Said, M. A. Copie et al., Cost of care distribution in atrial fibrillation patients: the COCAF study, Am Heart J. janv, vol.147, issue.1, pp.121-127, 2004.

R. P. Martins, K. Kaur, E. Hwang, R. J. Ramirez, B. C. Willis et al., Dominant frequency increase rate predicts transition from paroxysmal to long-term persistent atrial fibrillation, Circulation. 8 avr, vol.129, issue.14, pp.1472-82, 2014.

J. J. Goldberger, R. Arora, D. Green, P. Greenland, D. C. Lee et al., Evaluating the Atrial Myopathy Underlying Atrial Fibrillation: Identifying the Arrhythmogenic and Thrombogenic Substrate, Circulation. 28 juill, vol.132, issue.4, pp.278-91, 2015.

P. A. Wolf, R. D. Abbott, and W. B. Kannel, Atrial fibrillation as an independent risk factor for stroke: the Framingham Study, Stroke. août, vol.22, issue.8, pp.983-991, 1991.

J. B. King, P. N. Azadani, P. Suksaranjit, A. P. Bress, D. M. Witt et al., Left Atrial Fibrosis and Risk of Cerebrovascular and Cardiovascular Events in Patients With Atrial Fibrillation, J Am Coll Cardiol. 12 sept, vol.70, issue.11, pp.1311-1332, 2017.

P. Kirchhof, S. Benussi, D. Kotecha, A. Ahlsson, D. Atar et al., ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS, European Heart Journal, vol.37, issue.38, pp.2893-962, 2016.

E. J. Benjamin, P. A. Wolf, D. 'agostino, R. B. Silbershatz, H. Kannel et al., Impact of Atrial Fibrillation on the Risk of Death: The Framingham Heart Study, Circulation. 8 sept, vol.98, issue.10, pp.946-52, 1998.

T. Andersson, A. Magnuson, I. Bryngelsson, O. Frøbert, K. M. Henriksson et al., All-cause mortality in 272 186 patients hospitalized with incident atrial fibrillation 1995-2008: a Swedish nationwide long-term case-control study, Eur Heart J. 7 avr, vol.34, issue.14, pp.1061-1068, 2013.

A. Kishore, A. Vail, A. Majid, J. Dawson, K. R. Lees et al., Detection of atrial fibrillation after ischemic stroke or transient ischemic attack: a systematic review and meta-analysis, Stroke. févr, vol.45, issue.2, pp.520-526, 2014.

M. Grond, M. Jauss, G. Hamann, E. Stark, R. Veltkamp et al., Improved detection of silent atrial fibrillation using 72-hour Holter ECG in patients with ischemic stroke: a prospective multicenter cohort study, Stroke. déc, vol.44, issue.12, pp.3357-64, 2013.

G. Flaker, M. Ezekowitz, S. Yusuf, L. Wallentin, H. Noack et al., Efficacy and safety of dabigatran compared to warfarin in patients with paroxysmal, persistent, and permanent atrial fibrillation: results from the RE-LY (Randomized Evaluation of Long-Term Anticoagulation Therapy) study, J Am Coll Cardiol. 28 févr, vol.59, issue.9, pp.854-859, 2012.

S. H. Hohnloser, D. Pajitnev, J. Pogue, J. S. Healey, M. A. Pfeffer et al., Incidence of stroke in paroxysmal versus sustained atrial fibrillation in patients taking oral anticoagulation or combined antiplatelet therapy: an ACTIVE W Substudy, J Am Coll Cardiol, vol.50, issue.22, pp.2156-61, 2007.

R. G. Hart, L. A. Pearce, R. M. Rothbart, J. H. Mcanulty, R. W. Asinger et al., Stroke with intermittent atrial fibrillation: incidence and predictors during aspirin therapy. Stroke Prevention in Atrial Fibrillation -72 -Investigators, J Am Coll Cardiol. janv, vol.35, issue.1, pp.183-190, 2000.

H. Inoue, H. Atarashi, K. Okumura, T. Yamashita, N. Kumagai et al., Thromboembolic events in paroxysmal vs. permanent non-valvular atrial fibrillation. Subanalysis of the J-RHYTHM Registry, Circ J, vol.78, issue.10, pp.2388-93, 2014.

T. Fredriksson, V. Frykman, L. Friberg, F. Al-khalili, J. Engdahl et al., Usefulness of Short-Lasting Episodes of Supraventricular Arrhythmia (Micro-Atrial Fibrillation) as a Risk Factor for Atrial Fibrillation, The American Journal of Cardiology. oct, vol.122, issue.7, pp.1179-84, 2018.

B. S. Larsen, P. Kumarathurai, J. Falkenberg, O. W. Nielsen, and A. Sajadieh, Excessive Atrial Ectopy and Short Atrial Runs Increase the Risk of Stroke Beyond Incident Atrial Fibrillation, J Am Coll Cardiol. 21 juill, vol.66, issue.3, pp.232-273, 2015.

A. N. Ganesan, D. P. Chew, T. Hartshorne, J. B. Selvanayagam, P. E. Aylward et al., The impact of atrial fibrillation type on the risk of thromboembolism, mortality, and bleeding: a systematic review and metaanalysis, Eur Heart J. 21 mai, vol.37, issue.20, pp.1591-602, 2016.

B. A. Steinberg, A. S. Hellkamp, Y. Lokhnygina, M. R. Patel, G. Breithardt et al., Higher risk of death and stroke in patients with persistent vs. paroxysmal atrial fibrillation: results from the ROCKET-AF Trial, Eur Heart J. 1 févr, vol.36, issue.5, pp.288-96, 2015.

G. Lip, R. Nieuwlaat, R. Pisters, D. A. Lane, and H. Crijns, Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation, Chest. févr, vol.137, issue.2, pp.263-72, 2010.

D. E. Jonas, L. C. Kahwati, J. Yun, J. C. Middleton, M. Coker-schwimmer et al., Screening for Atrial Fibrillation With Electrocardiography: Evidence Report and Systematic Review for the US Preventive Services Task Force, JAMA. 7 août, vol.320, issue.5, pp.485-98, 2018.

M. R. Patel, K. W. Mahaffey, J. Garg, G. Pan, D. E. Singer et al., Rivaroxaban versus warfarin in nonvalvular atrial fibrillation, N Engl J Med. 8 sept, vol.365, issue.10, pp.883-91, 2011.
URL : https://hal.archives-ouvertes.fr/hal-01038111

, Apixaban versus Warfarin in Patients with Atrial Fibrillation | NEJM

D. Sur,

, Dabigatran versus Warfarin in Patients with Atrial Fibrillation | NEJM

D. Sur,

N. Dagres, T. Chao, G. Fenelon, L. Aguinaga, D. Benhayon et al., European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on arrhythmias and cognitive function: What is the best practice?, J Arrhythm. 23 mars, vol.34, issue.2, pp.99-123, 2018.

M. Ding and C. Qiu, Atrial Fibrillation, Cognitive Decline, and Dementia: an Epidemiologic Review, Curr Epidemiol Rep, vol.5, issue.3, pp.252-61, 2018.

A. Alonso and A. De-larriva, Atrial Fibrillation, Cognitive Decline and Dementia, Eur Cardiol. août, vol.11, issue.1, pp.49-53, 2016.

B. Freedman, T. S. Potpara, and G. Lip, Stroke prevention in atrial fibrillation, Lancet. 20 août, vol.388, pp.806-823, 2016.

H. Hohnloser, S. Capucci, A. Fain, E. Gold, M. R. Van-gelder et al., ASymptomatic atrial fibrillation and Stroke Evaluation in pacemaker patients and the atrial fibrillation Reduction atrial pacing Trial (ASSERT), American Heart Journal. 1 sept, vol.152, issue.3, pp.442-449, 2006.

J. S. Healey, S. J. Connolly, M. R. Gold, C. W. Israel, I. C. Van-gelder et al., Subclinical atrial fibrillation and the risk of stroke, N Engl J Med. 12 janv, vol.366, issue.2, pp.120-129, 2012.

B. Freedman, J. Camm, H. Calkins, J. S. Healey, M. Rosenqvist et al., Screening for Atrial Fibrillation: A Report of the AF-SCREEN International Collaboration, Circulation, vol.09, pp.1851-67, 2017.

T. Sanna, H. Diener, R. S. Passman, D. Lazzaro, V. Bernstein et al., Cryptogenic Stroke and Underlying Atrial Fibrillation, New England Journal of Medicine. 26 juin, vol.370, issue.26, pp.2478-86, 2014.

D. J. Gladstone, M. Spring, P. Dorian, V. Panzov, K. E. Thorpe et al., Atrial Fibrillation in Patients with Cryptogenic Stroke, New England Journal of Medicine. 26 juin, vol.370, issue.26, pp.2467-77, 2014.

R. Proietti, A. Hadjis, A. Alturki, G. Thanassoulis, J. Roux et al., A Systematic Review on the -73 -Progression of Paroxysmal to Persistent Atrial Fibrillation, JACC: Clinical Electrophysiology. juin, vol.1, issue.3, pp.105-120, 2015.

C. B. De-vos, G. Breithardt, A. J. Camm, P. Dorian, P. R. Kowey et al., Progression of atrial fibrillation in the REgistry on Cardiac rhythm disORDers assessing the control of Atrial Fibrillation cohort: clinical correlates and the effect of rhythm-control therapy, Am Heart J. mai, vol.163, issue.5, pp.887-93, 2012.

O. Hisashi, A. Yoshimori, I. Syuhei, A. Yuya, D. Kosuke et al., Progression From Paroxysmal to Sustained Atrial Fibrillation Is Associated With Increased Adverse Events, Stroke, vol.49, issue.10, pp.2301-2309, 2018.

C. B. De-vos, R. Pisters, R. Nieuwlaat, M. H. Prins, R. G. Tieleman et al., Progression from paroxysmal to persistent atrial fibrillation clinical correlates and prognosis, J Am Coll Cardiol. 23 févr, vol.55, issue.8, pp.725-756, 2010.


E. Svennberg, J. Engdahl, F. Al-khalili, L. Friberg, V. Frykman et al., Mass Screening for Untreated Atrial Fibrillation: The STROKESTOP Study, Circulation. juin, vol.131, issue.25, pp.2176-84, 2015.

F. R. Quinn and D. Gladstone, Screening for undiagnosed atrial fibrillation in the community: Current Opinion in Cardiology, janv, vol.29, issue.1, pp.28-35, 2014.

, A randomised controlled trial and cost-effectiveness study of systematic screening (targeted and total population screening) versus routine practice for the detection of atrial fibrillation in people aged 65 and over: The SAFE study. Health Technology Assessment, vol.9, 2005.

D. T. Linker, T. B. Murphy, and A. H. Mokdad, Selective screening for atrial fibrillation using multivariable risk models, Heart. 1 sept, vol.104, issue.18, pp.1492-1501, 2018.

A. Alonso, B. P. Krijthe, T. Aspelund, K. A. Stepas, M. J. Pencina et al., Simple risk model predicts incidence of atrial fibrillation in a racially and geographically diverse population: the CHARGE-AF consortium, J Am Heart Assoc. 18 mars, vol.2, issue.2, p.102, 2013.

R. B. Schnabel, L. M. Sullivan, D. Levy, M. J. Pencina, J. M. Massaro et al., Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort study, Lancet. 28 févr, vol.373, issue.9665, pp.739-784, 2009.

K. J. Brunner, T. J. Bunch, C. M. Mullin, H. T. May, T. L. Bair et al., Clinical predictors of risk for atrial fibrillation: implications for diagnosis and monitoring, Mayo Clin Proc, vol.89, issue.11, pp.1498-505, 2014.

A. M. Chamberlain, S. K. Agarwal, A. R. Folsom, E. Z. Soliman, L. E. Chambless et al., A Clinical Risk Score for Atrial Fibrillation in a Biracial Prospective Cohort, Am J Cardiol. janv, vol.107, issue.1, pp.85-91, 2011.

B. M. Everett, N. R. Cook, D. Conen, D. I. Chasman, P. M. Ridker et al., Novel genetic markers improve measures of atrial fibrillation risk prediction, Eur Heart J. 1 août, vol.34, issue.29, pp.2243-51, 2013.

N. Lowres, L. Neubeck, J. Redfern, and S. B. Freedman, Screening to identify unknown atrial fibrillation: A systematic review, Thrombosis and Haemostasis, vol.110, issue.08, pp.213-235, 2013.

R. The and . Study, Assessment of Remote Heart Rhythm Sampling Using the AliveCor Heart Monitor to Screen for Atrial Fibrillation, p.11

J. Engdahl, L. Andersson, M. Mirskaya, and M. Rosenqvist, Stepwise screening of atrial fibrillation in a 75-yearold population: implications for stroke prevention, Circulation. 26 févr, vol.127, issue.8, pp.930-937, 2013.

E. Pokushalov, A. Romanov, G. Corbucci, S. Artyomenko, A. Turov et al., Use of an implantable monitor to detect arrhythmia recurrences and select patients for early repeat catheter ablation for atrial fibrillation: a pilot study, Circ Arrhythm Electrophysiol. déc, vol.4, issue.6, pp.823-854, 2011.

N. Dagres, H. Kottkamp, C. Piorkowski, S. Weis, A. Arya et al., Influence of the duration of Holter monitoring on the detection of arrhythmia recurrences after catheter ablation of atrial fibrillation: implications for patient follow-up, Int J Cardiol. 18 mars, vol.139, issue.3, pp.305-311, 2010.

D. E. Jonas, L. C. Kahwati, J. Yun, J. C. Middleton, M. Coker-schwimmer et al., Screening for Atrial Fibrillation With Electrocardiography: Evidence Report and Systematic Review for the US Preventive Services Task Force, JAMA. 7 août, vol.320, issue.5, 2018.

K. Rahimi, Subclinical atrial fibrillation in need of more assertive evidence, Eur Heart J, vol.1, issue.17, pp.1345-1352

C. Martinez, A. Katholing, and S. B. Freedman, Adverse prognosis of incidentally detected ambulatory atrial fibrillation. A cohort study, Thromb Haemost. août, vol.112, issue.2, pp.276-86, 2014.

B. Freedman, C. Martinez, A. Katholing, and S. Rietbrock, Residual Risk of Stroke and Death in Anticoagulant-Treated Patients With Atrial Fibrillation, JAMA Cardiol, vol.01, issue.3, pp.366-374, 2016.

J. Engdahl, A. Holmén, M. Rosenqvist, and U. Strömberg, A prospective 5-year follow-up after populationbased systematic screening for atrial fibrillation, Europace, vol.20, issue.FI_3, pp.306-317, 2018.

M. Proietti, G. H. Mairesse, P. Goethals, C. Scavee, J. Vijgen et al., A population screening programme for atrial fibrillation: a report from the Belgian Heart Rhythm Week screening programme, Europace. déc, vol.18, issue.12, pp.1779-86, 2016.

N. Chan and C. Choy, Screening for atrial fibrillation in 13 122 Hong Kong citizens with smartphone electrocardiogram, Heart, vol.01, issue.1, pp.24-31, 2017.

N. Chan, C. Choy, C. Chan, and C. Siu, Effectiveness of a nongovernmental organization-led largescale community atrial fibrillation screening program using the smartphone electrocardiogram: An observational cohort study, Heart Rhythm, vol.15, issue.9, pp.1306-1317, 2018.

S. J. Curry, A. H. Krist, D. K. Owens, M. J. Barry, A. B. Caughey et al., Screening for Atrial Fibrillation With Electrocardiography: US Preventive Services Task Force Recommendation Statement, JAMA. 7 août, vol.320, issue.5, pp.478-84, 2018.

G. Cooke, J. Doust, and S. Sanders, Is pulse palpation helpful in detecting atrial fibrillation? A systematic review, J Fam Pract. févr, vol.55, issue.2, pp.130-134, 2006.

P. D. Ziegler, J. L. Koehler, and R. Mehra, Comparison of continuous versus intermittent monitoring of atrial arrhythmias, Heart Rhythm. déc, vol.3, issue.12, pp.1445-52, 2006.

D. J. Gladstone, M. Spring, P. Dorian, V. Panzov, K. E. Thorpe et al., Atrial fibrillation in patients with cryptogenic stroke, N Engl J Med. 26 juin, vol.370, issue.26, pp.2467-77, 2014.

G. Hindricks, E. Pokushalov, L. Urban, M. Taborsky, K. Kuck et al., Performance of a new leadless implantable cardiac monitor in detecting and quantifying atrial fibrillation: Results of the XPECT trial, Circ Arrhythm Electrophysiol. avr, vol.3, issue.2, pp.141-148, 2010.

Y. Bryan, P. , L. William, H. S. , C. Christy et al., Contact-Free Screening of Atrial Fibrillation by a Smartphone Using Facial Pulsatile Photoplethysmographic Signals, Journal of the American Heart Association, vol.7, issue.8, p.8585

L. Desteghe, Z. Raymaekers, M. Lutin, J. Vijgen, D. Dilling-boer et al., Performance of handheld electrocardiogram devices to detect atrial fibrillation in a cardiology and geriatric ward setting, Europace. 1 janv, vol.19, issue.1, pp.29-39, 2017.

F. Hobbs, D. A. Fitzmaurice, J. Mant, E. Murray, S. Jowett et al., A randomised controlled trial and cost-effectiveness study of systematic screening versus routine practice for the detection of atrial fibrillation in people aged 65 and over. The SAFE study, Health Technol Assess, vol.9, 2005.

J. Lau, N. Lowres, L. Neubeck, D. Brieger, R. Sy et al., Performance of an Automated iPhone ECG Algorithm to Diagnose Atrial Fibrillation in a, Community AF Screening Program (SEARCH-AF

, Heart, Lung and Circulation. janv, vol.22, p.205, 2013.

H. C. Bazett, An Analysis of the Time-Relations of Electrocardiograms, Annals of Noninvasive Electrocardiology, vol.2, issue.2, pp.177-94, 1997.

N. Lowres, L. Neubeck, G. Salkeld, I. Krass, A. J. Mclachlan et al., Feasibility and costeffectiveness of stroke prevention through community screening for atrial fibrillation using iPhone ECG in pharmacies. Thrombosis and Haemostasis, vol.111, pp.1167-76, 2017.

S. Morgan and D. Mant, Randomised trial of two approaches to screening for atrial fibrillation in UK general practice, Br J Gen Pract. mai, vol.52, issue.478, pp.373-80, 2002.

. Brjcardiol, The effectiveness of a mobile ECG device in identifying AF: sensitivity, specificity and predictive value |, The British Journal of Cardiology, p.75

, AliveCor® Kardia Mobile Mode d'emploi

L. Koltowski, P. Balsam, R. Gl?owczynska, J. K. Rokicki, M. Peller et al., Kardia Mobile applicability in clinical practice: A comparison of Kardia Mobile and standard 12-lead electrocardiogram records in 100 consecutive patients of a tertiary cardiovascular care center, Cardiology Journal

E. L. Veale, A. J. Stewart, A. Mathie, S. K. Lall, M. Rees-roberts et al., Pharmacists detecting atrial fibrillation (PDAF) in primary care during the influenza vaccination season: a multisite, cross-sectional screening protocol, BMJ Open, vol.14, issue.3, p.21121, 2018.

M. S. Jacobs, F. Kaasenbrood, M. J. Postma, M. Van-hulst, and R. G. Tieleman, Cost-effectiveness of screening for atrial fibrillation in primary care with a handheld, single-lead electrocardiogram device in the Netherlands, Europace. 1 janv, vol.20, issue.1, pp.12-20, 2018.

A. S. Gami, G. Pressman, S. M. Caples, R. Kanagala, J. J. Gard et al., Association of atrial fibrillation and obstructive sleep apnea, Circulation. 27 juill, vol.110, issue.4, pp.364-371, 2004.

I. H. Stevenson, H. Teichtahl, D. Cunnington, S. Ciavarella, I. Gordon et al., Prevalence of sleep disordered breathing in paroxysmal and persistent atrial fibrillation patients with normal left ventricular function, Eur Heart J. juill, vol.29, issue.13, pp.1662-1671, 2008.

Y. Kwon, R. J. Koene, A. R. Johnson, G. Lin, and J. D. Ferguson, Sleep, sleep apnea and atrial fibrillation: Questions and answers, Sleep Med Rev, vol.39, pp.134-176, 2018.

K. M. Porthan, J. H. Melin, J. T. Kupila, K. Venho, and M. M. Partinen, Prevalence of sleep apnea syndrome in lone atrial fibrillation: a case-control study, Chest. mars, vol.125, issue.3, pp.879-85, 2004.

N. Oza, S. Baveja, R. Khayat, and M. Houmsse, Obstructive sleep apnea and atrial fibrillation: understanding the connection, Expert Rev Cardiovasc Ther. mai, vol.12, issue.5, pp.613-634, 2014.

C. Guilleminault, S. J. Connolly, and R. A. Winkle, Cardiac arrhythmia and conduction disturbances during sleep in 400 patients with sleep apnea syndrome, Am J Cardiol. 1 sept, vol.52, issue.5, pp.490-494, 1983.

R. L. Verrier and M. E. Josephson, Impact of sleep on arrhythmogenesis, Circ Arrhythm Electrophysiol. août, vol.2, issue.4, pp.450-459, 2009.

E. Zhao, S. Chen, Y. Du, and Y. Zhang, Association between Sleep Apnea Hypopnea Syndrome and the Risk of Atrial Fibrillation: A Meta-Analysis of Cohort Study, Biomed Res Int, p.5215868, 2018.

P. Coumel, Cardiac arrhythmias and the autonomic nervous system, J Cardiovasc Electrophysiol. juin, vol.4, issue.3, pp.338-55, 1993.

, Recommandations pour la Pratique Clinique, Revue des Maladies Respiratoires. sept, vol.27, issue.7, pp.806-839, 2010.

P. R. Genta, L. F. Drager, and G. L. Filho, Screening for Obstructive Sleep Apnea in Patients with Atrial Fibrillation, Sleep Medicine Clinics. 1 mars, vol.12, issue.1, pp.99-105, 2017.

V. Hoffstein and S. Mateika, Differences in abdominal and neck circumferences in patients with and without obstructive sleep apnoea, Eur Respir J. avr, vol.5, issue.4, pp.377-81, 1992.

I. Katz, J. Stradling, A. S. Slutsky, N. Zamel, and V. Hoffstein, Do patients with obstructive sleep apnea have thick necks?, Am Rev Respir Dis. mai, vol.141, issue.5, pp.1228-1259, 1990.

V. Hoffstein and S. Mateika, Differences in abdominal and neck circumferences in patients with and without obstructive sleep apnoea, Eur Respir J. avr, vol.5, issue.4, pp.377-81, 1992.

R. J. Davies and J. R. Stradling, The relationship between neck circumference, radiographic pharyngeal anatomy, and the obstructive sleep apnoea syndrome, Eur Respir J. mai, vol.3, issue.5, pp.509-523, 1990.

P. J. Edmonds and L. C. Edmonds, A pilot study of the inability to fit hands around neck as a predictor of obstructive sleep apnea, North American Journal of Medical Sciences. 12 janv, vol.7, issue.12, p.553, 2015.

H. Abe, M. Takahashi, H. Yaegashi, S. Eda, H. Tsunemoto et al., Efficacy of continuous positive airway pressure on arrhythmias in obstructive sleep apnea patients, Heart Vessels. janv, vol.25, issue.1, pp.63-72, 2010.

D. Patel, P. Mohanty, D. Biase, L. Shaheen, M. Lewis et al., Safety and efficacy of pulmonary vein antral isolation in patients with obstructive sleep apnea: the impact of continuous positive airway pressure, Circ Arrhythm Electrophysiol, vol.3, issue.5, pp.445-51, 2010.

L. Li, Z. Wang, J. Li, X. Ge, L. Guo et al., Efficacy of catheter ablation of atrial fibrillation in patients with obstructive sleep apnoea with and without continuous positive airway pressure treatment: a meta-analysis of observational studies, Europace. sept, vol.16, issue.9, pp.1309-1323, 2014.

D. Patel, P. Mohanty, D. Biase, L. Shaheen, M. Lewis et al., Safety and efficacy of pulmonary vein antral isolation in patients with obstructive sleep apnea: the impact of continuous positive airway pressure, Circ Arrhythm Electrophysiol, vol.3, issue.5, pp.445-51, 2010.

J. M. Marin, S. J. Carrizo, E. Vicente, and A. Agusti, Long-term cardiovascular outcomes in men with obstructive -76 -sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study, Lancet. 19 mars, vol.365, issue.9464, pp.1046-53, 2005.

D. Linz, B. Linz, M. Hohl, and M. Böhm, Atrial arrhythmogenesis in obstructive sleep apnea: Therapeutic implications, Sleep Med Rev. avr, vol.26, pp.87-94, 2016.

A. Khan, J. Patel, D. Sharma, S. Riaz, S. Demissie et al., Obstructive Sleep Apnea Screening in Patients With Atrial Fibrillation: Missed Opportunities for Early Diagnosis, J Clin Med Res. janv, vol.11, issue.1, pp.21-26, 2019.

J. Wysocki, A. Charuta, K. Kowalcze, and I. Ptaszy?ska-sarosiek, Anthropometric and physiologic assessment in sleep apnoea patients regarding body fat distribution, Folia Morphol (Warsz), vol.75, issue.3, pp.393-402, 2016.

C. Tom, B. Roy, R. Vig, D. W. Kang, R. S. Aysola et al., Correlations between Waist and Neck Circumferences and Obstructive Sleep Apnea Characteristics, Sleep Vigil. déc, vol.2, issue.2, pp.111-119, 2018.

R. S. Kaulgud, A. Kaul, B. S. Arun, and P. B. Vijayalaxmi, Neck Circumference and Leg Length as Surrogate Markers of Coronary Artery Disease -Simplifying Cardiac Risk Stratification, J Clin Diagn Res. mai, vol.11, issue.5, pp.17-26, 2017.

Y. Luo, X. Ma, Y. Shen, Y. Xu, Q. Xiong et al., Neck circumference as an effective measure for identifying cardio-metabolic syndrome: a comparison with waist circumference, Endocrine. mars, vol.55, issue.3, pp.822-852, 2017.

Y. Dai, X. Wan, X. Li, J. E. Li, and X. , Neck circumference and future cardiovascular events in a high-risk population-A prospective cohort study, Lipids in Health and Disease. 5 mars, vol.15, issue.1, p.46, 2016.

J. Mandrola, A. Foy, and G. Naccarelli, Screening for Atrial Fibrillation Comes With Many Snags, JAMA Internal Medicine, vol.178, issue.10, p.1296, 2018.

K. Rajakariar, . Mbbs1, N. Anoop, . Koshy, . Sajeev et al., Modified Positioning of a Smartphone based Single-Lead Electrocardiogram Device Improves Detection of Atrial Flutter

B. Joung, J. M. Lee, K. H. Lee, T. H. Kim, E. K. Choi et al., Korean Guideline of Atrial Fibrillation Management, Korean Circ J. déc, vol.48, issue.12, pp.1033-80, 2018.

T. Chao, A. K. Tsao, H. Lin, Y. , C. Lo et al., Relationship between the CHADS(2) score and risk of very late recurrences after catheter ablation of paroxysmal atrial fibrillation, Heart Rhythm. août, vol.9, issue.8, pp.1185-91, 2012.

D. Kotecha, J. Holmes, H. Krum, D. G. Altman, L. Manzano et al., Efficacy of ? blockers in patients with heart failure plus atrial fibrillation: an individual-patient data meta-analysis, Lancet. 20 déc, vol.384, issue.9961, pp.2235-2278, 2014.

S. Marott, S. F. Nielsen, M. Benn, and B. G. Nordestgaard, Antihypertensive treatment and risk of atrial fibrillation: a nationwide study, Eur Heart J. mai, vol.35, issue.18, pp.1205-1219, 2014.

, Use of Irbesartan to Maintain Sinus Rhythm in Patients With Long-Lasting Persistent Atrial Fibrillation | Circulation

R. K. Pathak, M. E. Middeldorp, D. H. Lau, A. B. Mehta, R. Mahajan et al., Aggressive risk factor reduction study for atrial fibrillation and implications for the outcome of ablation: the ARREST-AF cohort study, J Am Coll Cardiol. 2 déc, vol.64, issue.21, pp.2222-2253, 2014.

A. M. Chamberlain, S. K. Agarwal, A. R. Folsom, S. Duval, E. Z. Soliman et al., Smoking and incidence of atrial fibrillation: results from the Atherosclerosis Risk in Communities (ARIC) study, Heart Rhythm. août, vol.8, issue.8, pp.1160-1166, 2011.

H. Wang, Q. Si, Z. Shan, Y. Guo, K. Lin et al., Effects of Body Mass Index on Risks for Ischemic Stroke, Thromboembolism, and Mortality in Chinese Atrial Fibrillation Patients: A Single-Center Experience, PLOS ONE. 7 avr, vol.10, issue.4, p.123516, 2015.

R. Kanagala, N. S. Murali, P. A. Friedman, N. M. Ammash, B. J. Gersh et al., Obstructive sleep apnea and the recurrence of atrial fibrillation, Circulation. 27 mai, vol.107, issue.20, pp.2589-94, 2003.

H. Marti-soler, C. Hirotsu, P. Marques-vidal, P. Vollenweider, G. Waeber et al., The NoSAS score for screening of sleep-disordered breathing: a derivation and validation study, The Lancet Respiratory Medicine. 1 sept, vol.4, issue.9, pp.742-750, 2016.

S. Garrigue, J. Pépin, P. Defaye, F. Murgatroyd, Y. Poezevara et al., High prevalence of sleep apnea syndrome in patients with long-term pacing: the European Multicenter Polysomnographic Study, Circulation. 3 avr, vol.115, issue.13, pp.1703-1712, 2007.